State Ledger
Company profile

Dianthus Therapeutics, Inc. /DE/ CIK 1690585

Ticker
DNTH (Nasdaq)
Industry
Pharmaceutical Preparations
Headquarters
New York, NY 10036
Fiscal year end
2025 (FY)
Market Data
Close
$81.68
Change
-$0.68
Change %
-0.82%
Volume
25,120

DNTH · trading date Oct 12, 2026 · previous close $82.36 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$2.04M
Net income
-$162.34M
Total assets
$530.92M
Total liabilities
$37.52M
Stockholders' equity
$493.40M
Cash & equivalents
$51.09M
Operating income
-$177.93M
Operating cash flow
-$129.06M
Capital expenditures
$213.0K

Fiscal year 2025, via 10-K filed 2026-03-09. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
-8,739.3%
Net margin
-7,973.3%
Free cash flow
-$129.27M
Free cash flow margin
-6,349.4%
Liabilities / assets
7.1%
Equity / assets
92.9%
CapEx / revenue
10.5%
Operating cash flow / net income
0.80×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $2.04M -$162.34M $530.92M $37.52M $493.40M
2024 $6.24M -$84.97M $374.01M $21.53M $352.48M
2023 $2.83M -$43.56M $179.41M $10.54M $168.87M
2022 — -$28.48M $83.11M $9.45M -$44.37M
2021 — -$71.14M $189.93M $17.26M -$17.25M
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 4
2026-09-18
Financials filed via
Form 10-K
filed 2026-03-09

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
New York, NY 10036
7 TIMES SQUARE
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:45 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to New York — Public Companies